Analysis of different human leukemias also gave fruitful results, especially in B-cell chronic lymphocytic leukemia (B-CLL).CD38 is a dependable marker for a subset of B-CLL patients and provides differential prognostic information [14]. This evidence concerns the gene CD38 and B-cell chronic lymphocytic leukemia.